BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2851236)

  • 21. Evidence for chemical differentiation of delta opioid receptor subtypes by the sulfhydryl reagent N-ethylmaleimide.
    Tam L; Rafferty MF
    Receptor; 1994; 4(2):81-91. PubMed ID: 7950982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y; Hiller JM; Simon EJ
    Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL; Brown SR; Puttfarcken P; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct measurements of in situ interactions of rat brain opioid receptors with the guanine nucleotide-binding protein Go.
    Georgoussi Z; Carr C; Milligan G
    Mol Pharmacol; 1993 Jul; 44(1):62-9. PubMed ID: 8393523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
    Gulya K; Lui GK; Pelton JT; Kazmierski W; Hruby VJ; Yamamura HI
    NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
    Geary WA; Wooten GF
    J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
    Michel ME; Bolger G; Weissman BA
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide.
    Ehlert FJ; Roeske WR; Yamamura HI
    J Supramol Struct; 1980; 14(2):149-62. PubMed ID: 7230804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of forskolin binding to rat brain membranes.
    Seamon KB; Vaillancourt R; Daly JW
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):535-49. PubMed ID: 4086675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
    Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3H]dynorphin1-8 binding sites in frog (Rana esculenta) brain membranes.
    Benyhe S; Simon J; Borsodi A; Wollemann M; Barnard EA
    Neuropeptides; 1994 May; 26(5):359-64. PubMed ID: 7915022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsomal opiate receptors: characterization of smooth microsomal and synaptic membrane opiate receptors.
    Roth BL; Coscia CJ
    J Neurochem; 1984 Jun; 42(6):1677-84. PubMed ID: 6327910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic activity and effects of guanyl-5'-yl imidodiphosphate, Gpp(NH)p and sodium ion on the affinity of dynorphin 1-13, nalorphine and nalorphine-7,8-oxide to kappa-opioid receptor.
    Takayanagi I; Okumura K; Konno F; Koike K; Cho N; Hirobe M
    Gen Pharmacol; 1985; 16(6):617-9. PubMed ID: 2867951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical characterization of [3H]tryptamine binding sites from rat brain.
    BrĂ¼ning G; Rommelspacher H
    Biochem Int; 1989 Jan; 18(1):227-33. PubMed ID: 2541722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A subset of kappa opioid ligands bind to the membrane glucocorticoid receptor in an amphibian brain.
    Evans SJ; Searcy BT; Moore FL
    Endocrinology; 2000 Jul; 141(7):2294-300. PubMed ID: 10875228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5'-Guanylylimidodiphosphate decreases affinity for agonists and apparent molecular size of a frog brain opioid receptor in digitonin solution.
    Mollereau C; Pascaud A; Baillat G; Mazarguil H; Puget A; Meunier JC
    J Biol Chem; 1988 Dec; 263(34):18003-8. PubMed ID: 2848020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of pH on stereospecific opiate binding to mouse brain membranes.
    Smith AP
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):375-98. PubMed ID: 19822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solubilization and purification of opioid receptor molecules of rat brain.
    Jin YC; Ye CY; Li Y; Suo CL; Li LY; Liu MQ; Jin XM; Mao ZM
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(1):1-7. PubMed ID: 2540493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.